Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Short term Debt (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Short term Debt for 12 consecutive years, with $500000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt fell 98.42% year-over-year to $500000.0, compared with a TTM value of $500000.0 through Sep 2025, down 98.42%, and an annual FY2025 reading of $500000.0, changed N/A over the prior year.
  • Short term Debt was $500000.0 for Q3 2025 at SRx Health Solutions, down from $1.1 million in the prior quarter.
  • Across five years, Short term Debt topped out at $31.6 million in Q3 2024 and bottomed at $500000.0 in Q3 2025.
  • Average Short term Debt over 5 years is $3.2 million, with a median of $1.2 million recorded in 2025.
  • The sharpest move saw Short term Debt skyrocketed 1547.1% in 2024, then crashed 98.42% in 2025.
  • Year by year, Short term Debt stood at $855000.0 in 2021, then surged by 124.8% to $1.9 million in 2022, then fell by 9.42% to $1.7 million in 2023, then skyrocketed by 38.66% to $2.4 million in 2024, then plummeted by 79.29% to $500000.0 in 2025.
  • Business Quant data shows Short term Debt for SRXH at $500000.0 in Q3 2025, $1.1 million in Q2 2025, and $1.2 million in Q1 2025.